Intervention

Gelesis200

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 4 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4
Recruiting0
Common conditions7
Lead sponsors shown1
Advertisement

Clinical trials

4 shown
Effects of Gelesis200 on Appetite Parameters, Food Intake, and Glycemic Control in Overweight or Obese Prediabetic Subjects: A Sub-Study of LIGHT-UPNCT03622424 · 2017-08-22
COMPLETED
Gelesis Glycemic Index StudyNCT03124134 · 2017-04-18
COMPLETED
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 DiabetesNCT03058029 · 2017-02-22
UNKNOWN
Gelesis200 Safety and Tolerability Study and Effects on Glycemic and Appetite ParametersNCT02652962 · 2016-01-01
COMPLETED

Trial status mix

COMPLETED3
UNKNOWN1

Phase mix

NA4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.